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Abstract
Background
Tendon-bone healing following rotator cuff repairs is mainly impaired by poor tissue quality.
Demineralised bone matrix promotes healing of the tendon-bone interface but its role in the
treatment of tendon tears with retraction has not been investigated. We hypothesized that
cortical demineralised bone matrix used with minimally manipulated mesenchymal stem
cells will result in improved function and restoration of the tendon-bone interface with no dif-
ference between xenogenic and allogenic scaffolds.
Materials and Methods
In an ovine model, the patellar tendon was detached from the tibial tuberosity and a com-
plete distal tendon transverse defect measuring 1 cm was created. Suture anchors were
used to reattach the tendon and xenogenic demineralised bone matrix + minimally manipu-
lated mesenchymal stem cells (n = 5), or allogenic demineralised bone matrix + minimally
manipulated mesenchymal stem cells (n = 5) were used to bridge the defect. Graft incorpo-
ration into the tendon and its effect on regeneration of the enthesis was assessed using his-
tomorphometry. Force plate analysis was used to assess functional recovery.
Results
Compared to the xenograft, the allograft was associated with significantly higher functional
weight bearing at 6 (P = 0.047), 9 (P = 0.028), and 12 weeks (P = 0.009). In the allogenic
group this was accompanied by greater remodeling of the demineralised bone matrix into
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tendon-like tissue in the region of the defect (p = 0.015), and a more direct type of enthesis
characterized by significantly more fibrocartilage (p = 0.039). No failures of tendon-bone
healing were noted in either group.
Conclusion
Demineralised bone matrix used with minimally manipulated mesenchymal stem cells pro-
motes healing of the tendon-bone interface in an ovine model of acute tendon retraction,
with superior mechanical and histological results associated with use of an allograft.
Introduction
The muscles of the rotator cuff (subscapularis, supraspinatus, infraspinatus, and teres minor)
play an important role in normal glenohumeral motion and stability. Some tears (deemed
‘irreparable rotator cuff tears’) cannot be repaired primarily to bone despite conventional tech-
niques of mobilization and soft-tissue releases because of their size and retraction [1]. They are
associated with atrophy and fatty infiltration of the associated rotator cuff muscles: this is
reflected in an alteration of their pennation angles, which results in impaired muscle contrac-
tion and altered joint biomechanics [2, 3]. Left untreated, irreparable tears frequently lead to
cuff tear arthropathy in susceptible individuals [4].
Poor biological healing following rotator cuff repair is a considerable problem, with failure
of tendon-bone fixation occurring in up to 26% of small to medium tears and up to 94% in
large and massive tears [5–9]. The cause of the high retear rate is multifactorial and may be
attributed to the older age of the patient, quality of the tissue, chronicity and size of the tear,
muscle atrophy, fatty infiltration, bone mineral density, and repair technique (single vs double
row repair) [10–13]. In selected patients, mechanical and biological enhancement of the ten-
don-bone interface may be integral to a successful outcome following surgery [14]. Surgical
options for treating irreparable rotator cuff tears include debridement +/- partial repair
(arthroscopic or open), tendon transfer, and non-anatomic arthroplasty. The best patient out-
comes are associated with tears that fully heal, however the results of surgery are varied and
failure has been demonstrated to occur in up to 94% of non-arthroplasty cases [5, 15]. Current
tissue engineering strategies to address this include scaffolds and biological factors, which can
be used either in isolation or combination [16]. Demineralised bone matrix (DBM) is a colla-
gen-based scaffold that is osteoinductive via endochondral ossification [17]. It is manufactured
by removing the mineral component of bone tissue and has been shown to regenerate a func-
tional enthesis with the formation of calcified and non-calcified cartilage interfacing bone and
tendon with ‘Sharpey’s-like’ collagen fibres [18]. A sustained release of growth factors, includ-
ing bone morphogenic proteins (BMPs), is thought to be responsible for this [17]. BMPs found
in DBM have been shown to result in differentiation of mesenchymal stem cells (MSCs) into
osteoblasts, chondrocytes and tenocytes but the direct effect of growth factors on intact tendon
tissue is unknown [19–23].
The purpose of this study was to evaluate the effect of allogenic and xenogenic DBM used
with autologous minimally manipulated MSCs (mmMSCs) on regeneration of the tendon-
bone interface in an ovine model of acute tendon retraction. Since xenografts are cheaper and
more readily available than their allogenic derivatives we wanted to assess their potential for
augmenting tendon-bone healing [24]. We hypothesized that augmentation of a healing
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tendon-bone interface with DBM and mmMSCs would result in improved function, and resto-
ration of the native enthesis, with no difference between xenogenic and allogenic scaffolds.
Materials and Methods
Study Design
All animal work was conducted in accordance with a Project License protocol accepted under
the UK Home Office Animals (Scientific Procedures) Act 1986 and all efforts were made to
minimize suffering. Ten skeletally mature non-pregnant female Friesland ewes, 2 to 3 years
old, weighing between 78 and 97 kg were selected for this study. All 10 animals underwent sur-
gical excision of the distal 1 cm of the right hind limb patellar tendon; the defect was repaired
using a strip of xenogenic (porcine)/allogenic (ovine) DBM and mmMSCs. Animals were mon-
itored continually throughout the experimental procedure by assessing baseline observations
such as heart rate, blood pressure, and respiratory rate. All procedures were carried out by one
surgeon. In keeping with the regulations set out by the UK Home Office Animals (Scientific
Procedures) Act 1986, a control group was not used in this study since previous work has
shown that a tendon defect does not heal spontaneously, rendering the animals lame [25, 26].
Animals were freely mobilized in individual pens with a constant supply of natural light and
fed on hay. Supplementary minerals and salts were provided to maintain the remaining dietary
requirements. At 12 weeks all animals were euthanised using intravenous Sodium Pentobarbi-
tal, following which specimens were retrieved. Force plate analysis, radiographs, pQCT scans,
and histological analysis were performed.
DBMmanufacture
DBM derived from cortical bone was manufactured according to Urist’s protocol, with modifi-
cations [17]. Six tibiae from three skeletally mature female ewes (allograft) and sows (xeno-
graft) were harvested immediately post euthanasia; all soft tissues and periosteum were
stripped from the bone surface. Proximal and distal ends of each tibia were excised and the
shafts were cut into three longitudinal sections corresponding to the three surfaces of the pris-
matic shape of the tibia using a diamond edged band saw (Exact, Hamburg, Germany). The
resulting bone strips were then demineralized in 0.6 N hydrochloric acid (HCL) at room tem-
perature. Demineralization was confirmed by taking radiographs (300 seconds, 30 kV, Faxitron
Corporation, Illinois, USA). This was followed by prolonged washing in phosphate buffered
saline (PBS) and lyophilisation (BOC Edwards, Crawley, West Sussex, UK) for storage. Strips
measuring 3–4 mm in thickness, 20 mm (+/- 2 mm) wide, and 15 cm long were cut and steril-
ized by gamma irradiation at a dose of 25 KGrays (Isotron, Reading, UK). Samples were rehy-
drated at the time of surgery in normal saline for 45 minutes prior to use.
Bone marrow aspiration
In order to deliver MSCs to the surgical site without expanding them using traditional time-
consuming tissue culture techniques, we used the buffy layer from centrifuged autologous bone
marrow aspirate obtained from the iliac crest at the time of surgery [27, 28]. Cells obtained in
this manner are deemed ‘minimally manipulated MSCs’ (also known as bone marrow aspirate
concentrates) and entail lower costs, faster processing, and less chance of an immunogenic
reaction [29, 30]. Following the induction of anaesthesia, 20 ml of marrow was aspirated from
the contralateral iliac crest in small fractions to reduce the degree of contamination by periph-
eral blood. Several aspirations were made through the same skin incision with each being
spaced approximately 1 cm apart to avoid dilution from aspiration in the previous channel. All
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aspirates were stored in vials containing heparin and then concentrated by centrifugation with
Ficoll for 30 minutes [27]. The buffy layer containing mmMSCs was returned to the operative
room after 45 minutes.
Surgical Procedure
An acute tendon retraction model was developed from a pre-existing ovine model used to
examine tendon-bone healing [18]. All animals were sourced from The Royal Veterinary Col-
lege (Hatfield, Hertfordshire, UK). Anaesthesia was induced with intravenous Midazolam (2.5
mg) and Ketamine Hydrochloride (2 mg/kg) and then maintained using 2% Isoflurane mixed
with pure oxygen via an endotracheal tube. A longitudinal skin incision was made over the
right stifle joint proximal to the upper pole of the patella to a point distal to the tibial tuberosity.
The patellar tendon was identified and a transverse strip of the distal 1 cm was excised from its
attachment (Fig 1A). Complete surgical avulsion of the patellar tendon insertion was con-
firmed by retraction of the proximal patellar tendon from the tibial tuberosity. The tendon
insertion footprint was prepared by osteotomising the superficial 3 mm of bone with a sagittal
saw parallel to the long axis of the tibia, and two 3.2 mm drill holes were made 1 cm apart on
the prepared flat bone surface into which two 5.5 mm suture anchors (Corkscrew, Arthrex,
Naples, Florida, USA) for reattachment of the DBM strip were inserted using a standard
Fig 1. A. Ovine patellar-tendon defect. B. Osteotomised tibial tuberosity with two suture anchors in situ. The
defect was repaired with allograft in five sheep and with xenograft in the remaining five sheep. An interlocking
Krakow suture technique was used to secure the DBM strip to the remaining proximal patellar tendon using a
#2 FiberWire (Fig 1C). The distal end of the DBM strip overlying the tibial tuberosity was secured to the
prepared flat surface using the two anchors and its margins sutured to the surrounding tissue to ensure
consistent and complete contact with the bony footprint. The dimensions of the DBM strip were adjusted to
match the length and width of the host patellar tendon prior to repair: averaged 20 mmwide and 100 mm long.
The surgical wound was closed in layers using absorbable Vicryl sutures. The sheep were allowed to move
freely postoperatively without restraint. Animals received intravenous Buprenorphine at a dose of 0.006–0.01
mg/kg for a maximum of four days after surgery. Digital lateral X-ray radiographs of both hind limbs were
taken at 12 weeks. Fig 1C. Ovine patellar tendon defect repaired with allogenic DBM.
doi:10.1371/journal.pone.0161473.g001
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surgical technique (Fig 1B). The buffy layer was mixed with the fibrinogen component of a
fibrin sealant (Tisseel, Baxter Health Care, Berkshire, United Kingdom) and then mixed with
the thrombin component and applied onto the osteotomy site. Delivering MSCs in this way
has been shown not to interfere with their proliferation or viability [31, 32].
Force Plate Analysis
Animals underwent force plate analysis pre-operatively and at 6, 9, and 12 weeks postopera-
tively as this has been demonstrated to be an appropriate marker of functional recovery [18].
Twelve readings of each hind limb were taken by walking the animals over a force plate (Kistler
Biomechanics Limited, Alton, UK) in a gait analysis laboratory. The mean peak vertical com-
ponent of the ground reaction force (GRFz) of each hind limb was obtained and normalized
for weight (Fmax/weight). Functional weight bearing (FWB) was expressed as the mean GRFz
of the right hind limb as a percentage of the left (control) limb. Improvements in FWB were
compared statistically between groups at each time point.
Peripheral quantitative computed tomography
Peripheral quantitative computed tomography (pQCT) scanning was performed to examine
for ossification within the patellar tendon, the DBM and surrounding tissues; 5 mm CT slices
were taken through the tibial tuberosity, patellar tendon/DBM and patella. pQCT was under-
taken, when specimens were retrieved at 12 weeks, using an XCT 2000 Bone Scanner (Stratec
Medizintechnik Gmbh, Germany) with Software version 6.20.
Histology
At 12 weeks the patella-patellar tendon/DBM graft-tibial tuberosity complex was harvested.
Visual assessment of the tissue during the dissection, and pQCT were undertaken to determine
if ossification had occurred at the margins of the graft. Samples were fixed in 10% formal saline
and underwent ascending graded alcohol dehydration, defatting in chloroform, and embed-
ding in LRWhite Hard Grade Resin (London Resin Company Limited, Reading, UK). Sections
were cut, ground, and polished to 70–100 μm before staining with Toluidine Blue and Paragon.
Three distinct zones were defined and evaluated by two observers blinded to the origin of
the graft (Fig 2). These comprised: zone 1, DBM-patellar tendon interface; zone 2, DBM in the
region of the tendon defect; zone 3, DBM neo-enthesis, (the area of the new tendon enthesis
over the tibial tuberosity). Sections were assessed for new bone formation, inflammatory cells,
cellularity, vascularization and collagen fibre crimp.
Fig 2. Threemorphological zones examined histologically. Zone 1: DBM-patellar tendon interface;
Zones 2: DBM in the region of the tendon defect; Zone 3: DBM neo-enthesis, examining the area of the new
tendon enthesis over the tibial tuberosity.
doi:10.1371/journal.pone.0161473.g002
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Semi-quantitative analysis was undertaken for interactions between DBM and the patellar
tendon (zone 1), remodeling of the DBM in the tendon defect (zone 2), and the formation of a
neo-enthesis (zone 3). In Zone 1, four separate equally spaced regions were analysed in order
to comprehensively examine the entire length of the DBM-patellar tendon interface. The maxi-
mum score for this area was therefore 20, in contrast to Zones 2 and 3 that could each yield a
maximum score of 5. Tables 1 and 2 describe the scoring criteria used for these assessments.
Statistical Analysis
Numerical data were inputted into SPSS software package, version 23 (SPSS Inc, an IBM Com-
pany, Chicago, Illinois). MannWhitney U tests were used to compare data between groups,
whilst Wilcoxon Signed Rank tests were used to assess differences within each group over time.
Results were considered significant at the p< 0.05 level.
Table 1. Criteria for semi-quantitative analysis of demineralised bonematrix remodelling (Zones 1
and 2).
Score Criteria
1 • DBM still present with no evidence of tendon integration
2 • DBM: very little evidence of remodelling and integration
• Collagen: poorly aligned, poorly organised, not parallel
3 • DBM: partial remodelling
• Collagen: partially aligned in a parallel manner, partially organised
4 • DBM: almost completely remodelled
• Collagen: mostly aligned in parallel fashion
5 • Completely remodelled DBM
• Normal tendon:
- Parallel aligned collagen ﬁbres
- Elongated ﬁbroblast nuclei
doi:10.1371/journal.pone.0161473.t001
Table 2. Criteria for semi-quantitative analysis of the tendon-bone interface (Zone 3).
Score Criteria
1 • No ﬁbrocartilage
• No mineralized ﬁbrocartilage
2 • Fibrocartilage present
• No mineralized ﬁbrocartilage
3 • Fibrocartilage present
• Mineralized ﬁbrocartilage present
• Disorganized arrangement
4 • Fibrocartilage present
• Mineralized ﬁbrocartilage present
• Organized graduation between distinct regions but no tidemark
5 • Fibrocartilage present
• Mineralized ﬁbrocartilage present
• Organized graduation between distinct regions with tidemark
doi:10.1371/journal.pone.0161473.t002
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Results
All animals survived the duration of the study and none had post-operative infection or failure
of the fixation, as noted on radiographs. At 12 weeks, the gait pattern had returned to normal
in both groups.
Force Plate Analysis
In the allograft group, FWB reached a median of 55.2% (range, 33.5–75.1) at 6 weeks, 68.1%
(range, 49.0–93.0) at 9 weeks, and 81.0% (range, 79.6–87.8) at 12 weeks. A significant improve-
ment was noted between 6 and 9 weeks (p = 0.043). In the xenograft group, FWB reached a
median of 39.1% (range, 29.7–48.5) at 6 weeks, 43.7% (range, 33.6–54.4) at 9 weeks, and 47.0%
(range, 41.7–74.1) at 12 weeks. A significant improvement was noted between 6 and 9 weeks
(p = 0.043). At 6, 9, and 12 weeks, FWB was significantly greater in the allograft group com-
pared with the xenograft group (p = 0.047, 0.028, and 0.021, respectively) (Fig 3).
pQCT Scans
None of the specimens showed any evidence of ossification within the DBM or the substance
of the patellar tendon.
Gross and Histological Findings
Normal post-operative scar tissue was present and there was no evidence of inflammatory reac-
tion, infection or excessive granulation tissue. The DBM was well integrated into both the tibial
tuberosity and patellar tendon and as no longer visible. The suture anchors remained well fixed
with no evidence of pull out or migration. All suture materials were found intact with no evi-
dence of rupture or failure.
Fig 3. Box and whiskers plot showing percentage functional weight bearing of allogenic and
xenogenic DBM groups at 6, 9 and 12 weeks.
doi:10.1371/journal.pone.0161473.g003
Augmentation of Tendon-Bone Healing Using Demineralised Bone Matrix
PLOS ONE | DOI:10.1371/journal.pone.0161473 September 8, 2016 7 / 14
At 12 weeks, both allogenic and xenogenic DBM was well integrated into the surrounding
peritendinous tissue with evidence of neovascularization. In the allograft group, the DBM-
patellar tendon interface (zone 1) and tendon defect (zone 2) appeared normal and both were
characterized by well-organized, crimped collagen fibres with elongated fibroblast nuclei (Fig
4a and 4c). At the tendon-bone interface (zone 3), this was accompanied by mineralized fibro-
cartilage comprising chondrocytes surrounded by a mineralized matrix (Fig 4e). This direct
type of enthesis, with a characteristic transition between bone, mineralized fibrocartilage,
demineralized fibrocartilage and tendon was seen in both groups. However the xenograft DBM
possessed fewer regions of mineralized fibrocartilage at the tendon-bone interface and dis-
played a more disorganised DBM-patellar tendon interface with fewer crimped collagen fibres
(Fig 4b, 4d and 4f). No evidence of heterotopic ossification or inflammatory cells was observed
in either group.
Semi-quantitative Histology
At 12 weeks, the remodeling of the DBM was assessed using the criteria outlined in Table 1. In
the region of the DBM-patellar tendon interface (zone 1), this scored a median of 14 (range,
Fig 4. Photomicrographs showing appearance of DBM allograft and xenograft at 12 weeks. Specimens
stained with Toluidine Blue and Paragon. (a) Zone 1: Patellar tendon-DBM allograft interface characterized
by well-organized, crimped collagen fibres with elongated fibroblast nuclei. (b) Zone 1: Patellar tendon-DBM
xenograft interface characterized by well-organized, crimped collagen fibres with elongated fibroblast nuclei.
(c) Zone 2: Tendon defect with complete remodeling of DBM allograft and large areas of well-organized,
crimped collagen fibres with elongated fibroblast nuclei. (d) Zone 2: Tendon defect with complete remodeling
of DBM xenograft and large areas of well-organized, crimped collagen fibres with elongated fibroblast nuclei.
(e) Zone 3: Allogenic DBM neo enthesis comprising tendon (T), fibrocartilage (FC), mineralized fibrocartilage
(MFC) and bone (B). (f) Zone 3: Xenogenic DBM neo enthesis comprising disorganised tendon (T),
fibrocartilage (FC), mineralized fibrocartilage (MFC) and bone (B).
doi:10.1371/journal.pone.0161473.g004
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11–16) in the allograft group and 12 (range, 11–15) in the xenograft group. This difference did
not reach statistical significance (p = 0.147). At the tendon defect (zone 2), this scored a median
of 4 (range, 3–5) in the allograft group and 3 (range, 2–4) in the xenograft group. In this region,
the remodeled allograft resembled native tendon tissue significantly more than the xenograft
(p = 0.015).
Analysis of the neo-enthesis (zone 3) was conducted using the criteria detailed in Table 2
with evaluation of the maturation of the enthesis and the presence of the four distinct zones
(tendon, demineralized fibrocartilage, mineralized fibrocartilage and bone). This scored a
median of 4 (range, 4–5) in the allograft group and 4 (range, 2–4) in the xenograft group. A sig-
nificantly more mature neo-enthesis was formed in the allograft group (p = 0.039).
Discussion
We have shown that allogenic and xenogenic DBM, used with mmMSCs, can regenerate an
enthesis with favorable histological and functional properties in an ovine model of acute ten-
don retraction. All animals survived the duration of the study and there were no cases of post-
operative infection or failure of the fixation. In both groups there was an improvement in func-
tional weight bearing at all time points, but this was noted to be significantly greater in those
animals that were treated with the allograft. At 12 weeks, the DBM had remodeled across the
entire length of the patellar tendon including the defect. Histologically, it was characterized by
well-organised crimped collagen fibres orientated in the direction of stress loading. The con-
struct was well cellularised and vascularized throughout. At the tendon defect, the allograft was
significantly more mature and had remodeled into tendon-like tissue with crimped collagen
fibers orientated in the direction of the tendon to a greater extent than the xenograft. The ten-
don-bone interface had been restored in both groups and was defined by the four distinct
regions that make up a direct enthesis. This was significantly more mature and organized in
the allograft group. We speculate that the allogenic scaffold exhibited superior results com-
pared to its xenogenic derivative because ovine bone has been demonstrated to contain a
greater proportion of high-density bone particles than porcine bone, and a higher bone mineral
content, bone mineral density, and fracture stress [33]. In this study, where a model of acute
tendon retraction was used, it is plausible that the substantial forces borne by the scaffold may
have resulted in repetitive micro-trauma of the weaker xenograft and consequently, inferior
histological and functional outcomes.
Endochondral ossification has been proposed as a potential mechanism responsible for the
development of the native enthesis [34]. It involves the initial release of growth factors followed
by the secretion of a cartilaginous matrix that undergoes mineralization and remodeling to
form bone [34]. This process is mediated by a number of growth factors including BMP-2 and
BMP-7. These have been shown to specifically lead to bony ingrowth and osseous integration
between tendon and bone, thereby strengthening the tendon attachment [35, 36]. DBM
induces new bone formation by a similar process and may therefore represent a suitable scaf-
fold to regenerate a functional tendon-bone interface [17]. Lovric et al [37] examined the effect
of a DBM paste on healing of a bone tunnel during anterior cruciate ligament (ACL) recon-
struction in a rodent model. At six weeks, peak load to failure was significantly higher in the
DBM group when compared to non-augmented controls. Increased woven bone formation at
the healing interface and greater expression of BMP-2 and BMP-7 were thought to be responsi-
ble for this. Histology did not show any evidence of fibrocartilage formation and the collagen
present at the enthesis was disorganized and immature. Sundar et al [18] examined functional
recovery of the ovine patella tendon-bone interface following tendon reattachment with a
DBM scaffold. Repair failure was noted in 33% of non-augmented controls. In contrast, none
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of the repairs failed in the DBM group and the resultant enthesis comprised new bone and
fibrocartilage. Earlier mobilization and superior function was noted at all time points.
Kilicoglu et al [38] assessed the effect of DBM on fixation of the extensor digitorum longus
tendon within a proximal tibial bone tunnel in a rabbit model. At three weeks a greater propor-
tion of Sharpey’s fibers, fibrocartilage and new bone was found in the DBM group when com-
pared to non-augmented controls. To further evaluate the influence of DBM on tendon-bone
healing within a bony tunnel, Hsu and Wang [39] used a rabbit model of ACL reconstruction.
Similar to previous reports, DBM was associated with new bone formation and greater miner-
alized fibrocartilage.
MSCs have the potential to differentiate into tenocytes, chondrocytes, and osteoblasts, as
well as being a rich source of growth factors that can enhance bone and tendon regeneration
[40]. The delivery of MSCs to a specific anatomical site has traditionally been achieved by
expansion in vitro, followed by either seeding onto a scaffold or direct implantation. Harvesting
autologous bone marrow-derived MSCs is an appealing option since the aspirate can be con-
centrated and made available within 45 minutes, negating the need for time consuming cul-
ture-based expansion [27, 28, 40]. MSCs used in isolation to treat tendon defects have yielded
variable results. Awad et al [41] examined the results of a full thickness patellar tendon defect
repaired in rabbits using culture-expanded MSCs within a collagen gel. Compared to controls,
the treatment group exhibited superior biomechanical properties but no differences in histo-
logical appearance. Juncosa-Melvin et al [42] evaluated the results of a collagen sponge,
implanted with culture-expanded MSCs, that was used to repair a full thickness patellar tendon
defect in rabbits. At 12 weeks, there was no difference in cellularity between the MSC group
and non-augmented controls. No fibrocartilage was found in either group and the biomechani-
cal properties of the MSC group were superior.
Our results of tendon-bone healing enhanced with DBM and mmMSCs contrast the afore-
mentioned studies in that both the histological and functional properties were enhanced. We
speculate that the increased amounts of BMPs present in DBM [37] caused the locally applied
mmMSC population to differentiate down osteoblastic, chondrocytic, and tenocytic lineages
[19–22]. The resultant interface resembled a direct enthesis containing organised fibrocartilage,
and was able to resist the strong forces applied to it throughout the postoperative period with-
out failure. Early postoperative weight bearing leading to mechanotransduction may have con-
tributed to this since applying load to a developing enthesis causes bone at the insertion site to
mature, increases fibrocartilage formation, and improves collagen organization [34]. Together,
these factors contribute to the formation of a direct enthesis capable of resisting physiological
forces.
We have used an ovine patellar tendon model to assess tendon-bone healing with DBM aug-
mentation to simulate the clinical condition of the repair of an acutely retracted tendon.
Despite this model not precisely representing chronic rotator cuff tears in a clinical setting due
to the lack of degeneration associated with creating an acute tear, it does permit an accurate
assessment of a healing enthesis as the extensor mechanism in a sheep has no supporting sub-
sidiary structures and is entirely dependent upon the attachment of the patellar tendon to the
tibial tuberosity. Detachment of supraspinatus in a sheep, and other animal models, would
have had a substantially lesser effect on gait function as other components of the rotator cuff
can compensate for its loss [43]. Other limitations of this study are associated with not quanti-
fying the precise cell numbers in the mononuclear fraction, the influence of inter-species varia-
tion on the structure of DBM, and the lack of a control group. However, not treating the
tendon defect would have rendered the animals lame, and therefore the study unethical, since
previous work has shown that spontaneous healing does not occur [25, 26]. Future areas of
study should examine the precise cellular mechanism involved in DBM enhancement of
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tendon-bone healing and compare it to other commercially available scaffolds, which are indi-
cated for tendon repair back to bone following retraction.
Conclusion
In conclusion, this is the first study to examine the effect of DBM used with mmMSCs on heal-
ing of a tendon-bone defect simulating acute tendon retraction. All animals were allowed unre-
stricted activity following surgery, which led to no failures. At 12 weeks, the tendon defect had
successfully remodeled into tendon-like tissue and was accompanied by a direct enthesis. Func-
tional weight bearing improved at all time points. Superior biomechanical and histological
results were noted with the allogenic scaffold, highlighting the potential for DBM to be consid-
ered in the clinical setting to augment rotator cuff tendon-bone healing where retraction com-
pounds conventional treatment strategies.
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